Syncom Formulations (India) Limited — Others, 25-06-2025: Disclosure under SEBI Takeover Regulations

Kedarmal Shankarlal Bankda, Promoter and Chairman of Syncom Formulations (India) Limited, along with Persons Acting in Concert, confirmed no new encumbrances on the company’s securities beyond those already disclosed for the financial year ended March 31, 2025. Certain shares held by Kedarmal Bankda (2.4 Cr) and Vimla Bankda (4.0047 Cr) remain locked-in due to a preferential issue and warrant conversions, restricting their marketability until the lock-in period ends. This update clarifies the current shareholding restrictions impacting liquidity for these promoter holdings.